Analysis of Cysteine-Linked Antibody Drug Conjugates
Applications | 2017 | Agilent TechnologiesInstrumentation
HPLC
IndustriesClinical Research
ManufacturerAgilent Technologies
Key wordsbrentuximab, vedotin, dar, hic, drug, antibody, hydrophobic, mmae, adcs, adc, tige, interaction, mab, linked, cysteine, trastuzumab, sulfhydryl, cleavable, molecules, mau, found, attached, analysis, cytotoxic, spacer, protease, bio, area, time, buffer, used, conjugated, conjugates, inert, species, characterization, benzyloxycarbonyl, rvaria, isopropyl, min, antibodies, frequently, small, amount, precision, monoclonal, percentage, adcetris, dissolved, ite
Similar PDF
Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods
2024|Agilent Technologies|Guides
Consumables Workflow Ordering Guide Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods Antibody Drug Conjugates Antibody-drug conjugates (ADCs) represent a new generation of targeted biotherapeutics that make up a rapidly growing segment of the drug discovery pipeline.…
Key words
mylist, mylistcysteine, cysteinedar, daradc, adcadcs, adcslysine, lysinelinker, linkercolumn, columnhic, hicauristatin, auristatinvedotin, vedotinantibody, antibodymmae, mmaeintact, intactinfinitylab
High Salt—High Reproducibility - Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System
2020|Agilent Technologies|Applications
Application Note Biopharma High Salt—High Reproducibility Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System Response (mAU) ×101 D2 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 1.2…
Key words
dar, darhic, hicbrentuximab, brentuximabvedotin, vedotinantibody, antibodydrug, drugsubtraction, subtractionbiocompatible, biocompatiblearea, areaadc, adcsalt, saltmolecules, moleculesmau, mauprecision, precisionspecies
Convenient and Reliable Analysis of Antibody Drug Conjugates
2021|Agilent Technologies|Applications
Application Note Biopharma/Pharma Convenient and Reliable Analysis of Antibody Drug Conjugates Drug-to-antibody determination with ternary gradients on the Agilent 1260 Infinity II Prime Bio LC ×101 1.20 D2 1.15 1.10 1.05 1.00 0.95 0.90 0.85 0.80 D4 0.75 Response (mAU)…
Key words
brentuximab, brentuximabvedotin, vedotinisopropanol, isopropanolhic, hicternary, ternarydar, darspecies, speciesantibody, antibodyorganic, organicbio, biodrug, drugbuffers, bufferssolvent, solventsalt, saltadcs
Fraction Analysis of Cysteine‑Linked Antibody-Drug Conjugates Using Hydrophobic Interaction Chromatography
2017|Agilent Technologies|Applications
Application Note Biologics & Biosimilars Fraction Analysis of Cysteine‑Linked Antibody-Drug Conjugates Using Hydrophobic Interaction Chromatography Agilent 1260 Infinity II Bio-Inert System mAU 700 600 500 400 300 200 100 0 5.0 Author Sonja Schneider Agilent Technologies, Inc Waldbronn, Germany 7.5…
Key words
fraction, fractionhic, hicbrentuximab, brentuximabmau, mauvedotin, vedotincollection, collectionfractionation, fractionationcollector, collectorfractions, fractionshydrophobic, hydrophobicantibody, antibodymin, minconjugates, conjugatescysteine, cysteinedrug